CN Stock MarketDetailed Quotes

300791 Sirio Pharma

Watchlist
  • 28.13
  • +0.38+1.37%
Trading Dec 2 13:33 CST
6.64BMarket Cap19.77P/E (TTM)

Sirio Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
21.80%3.05B
28.85%1.99B
35.51%951.5M
42.87%3.58B
39.96%2.5B
39.00%1.54B
66.69%702.16M
5.84%2.51B
2.31%1.79B
-4.60%1.11B
Operating revenue
21.80%3.05B
28.85%1.99B
35.51%951.5M
42.87%3.58B
39.96%2.5B
39.00%1.54B
66.69%702.16M
5.84%2.51B
2.31%1.79B
-4.60%1.11B
Other operating revenue
----
270.72%13.91M
----
-1.94%13.91M
----
8.96%3.75M
----
-62.66%14.19M
----
11.54%3.44M
Total operating cost
22.03%2.81B
26.36%1.83B
28.65%879.05M
46.34%3.31B
43.91%2.31B
44.60%1.44B
63.13%683.27M
7.19%2.26B
4.44%1.6B
-0.63%998.97M
Operating cost
19.95%2.1B
24.11%1.35B
29.99%660.17M
44.76%2.5B
41.85%1.75B
44.14%1.09B
67.65%507.88M
8.27%1.73B
6.16%1.23B
-0.52%756.11M
Operating tax surcharges
38.68%22.13M
40.79%13.31M
51.47%6.94M
50.90%22.41M
45.57%15.96M
30.74%9.45M
52.77%4.58M
3.17%14.85M
4.09%10.96M
2.93%7.23M
Operating expense
25.62%232.82M
36.31%155.86M
39.75%73.09M
113.33%277.61M
113.85%185.35M
127.55%114.35M
132.01%52.3M
-12.58%130.13M
-18.06%86.67M
-28.10%50.25M
Administration expense
20.98%296.97M
19.49%197.65M
10.74%91.97M
15.24%350.83M
14.23%245.46M
16.08%165.41M
35.91%83.05M
24.45%304.44M
25.12%214.88M
26.42%142.49M
Financial expense
87.03%66.06M
103.02%38.5M
31.80%16.08M
629.63%52.31M
1,124.70%35.32M
480.90%18.96M
15.93%12.2M
-72.79%7.17M
-113.32%-3.45M
-78.63%3.26M
-Interest expense (Financial expense)
46.78%73.39M
43.50%45.96M
53.90%17.8M
48.58%61.86M
265.74%50M
263.41%32.02M
143.46%11.56M
209.88%41.63M
-55.40%13.67M
-47.03%8.81M
-Interest Income (Financial expense)
44.53%-4.86M
-4.29%-3.4M
21.93%-1.4M
39.40%-7.02M
-1.89%-8.76M
26.42%-3.26M
26.33%-1.79M
-65.57%-11.58M
33.25%-8.6M
41.09%-4.43M
Research and development
30.68%98.63M
44.73%67.29M
36.99%30.79M
36.89%110.49M
24.24%75.47M
17.35%46.5M
20.05%22.48M
-2.97%80.72M
2.53%60.75M
-1.91%39.62M
Credit Impairment Loss
132.40%146.18K
-52.08%1.16M
-95.91%69.47K
-29.64%-5.18M
-128.20%-451.13K
433.55%2.42M
-38.93%1.7M
-314.19%-3.99M
260.80%1.6M
45.66%-725.99K
Asset Impairment Loss
-169.52%-2.23M
9.68%-2.03M
-242.54%-1.36M
108.15%405.38K
62.37%-828.29K
21.30%-2.24M
51.42%-397.78K
-142.00%-4.98M
-207.12%-2.2M
-4,402.67%-2.85M
Adjustment items of total operating cost
----
----
----
----
----
----
--780.11K
----
----
----
Other net revenue
2,488.44%12.2M
189.41%7.57M
-92.47%457.3K
-43.99%11.58M
-98.05%471.35K
-85.19%2.62M
-60.39%6.08M
-35.48%20.67M
4.17%24.17M
28.27%17.67M
Fair value change income
133.46%4.29M
137.52%2.62M
242.62%2.74M
-3,421.47%-57.67M
-2,212.21%-12.82M
-42,632.57%-6.98M
-59.87%800.27K
-56.51%-1.64M
241.97%606.77K
98.65%-16.33K
Invest income
-194.20%-3.75M
-239.60%-3.75M
-589.44%-4.87M
-90.51%2.22M
-66.78%3.98M
-78.26%2.69M
-76.08%994.85K
-7.13%23.39M
-20.63%11.99M
15.78%12.37M
Asset deal income
476.25%131.96K
180.12%131.96K
--131.96K
-76.37%34.01K
59.13%22.9K
261.50%47.11K
----
-5.92%143.93K
101.76%14.39K
1,547.71%13.03K
Other revenue
28.93%13.62M
41.34%9.44M
25.72%3.75M
827.75%71.77M
-13.14%10.56M
-24.80%6.68M
-58.67%2.98M
-28.06%7.74M
10.02%12.16M
55.81%8.88M
Operating profit
24.99%246.93M
67.88%172.81M
192.06%72.91M
6.40%282.02M
-5.99%197.56M
-20.88%102.94M
40.68%24.97M
-8.54%265.06M
-11.35%210.15M
-25.01%130.1M
Add:Non operating Income
41.55%1.82M
217.14%1.7M
371.52%1.15M
60.77%1.36M
55.16%1.29M
-57.05%536.65K
-78.61%244.59K
-58.20%848.83K
-8.74%828.46K
54.80%1.25M
Less:Non operating expense
222.03%6.8M
769.66%6.33M
1,557.87%4.74M
-29.57%10.13M
-75.43%2.11M
-88.78%727.87K
-73.64%286.1K
31.45%14.39M
3.33%8.59M
162.33%6.49M
Total profit
22.98%241.95M
63.69%168.19M
178.15%69.32M
8.64%273.26M
-2.79%196.73M
-17.71%102.75M
39.99%24.92M
-10.46%251.52M
-11.87%202.39M
-27.33%124.86M
Less:Income tax cost
-21.08%29.22M
41.51%32.27M
150.64%15.45M
-15.97%32.97M
41.23%37.03M
52.58%22.8M
94.75%6.17M
-20.04%39.23M
-10.40%26.22M
-42.62%14.95M
Net profit
33.20%212.73M
70.01%135.92M
187.19%53.87M
13.19%240.29M
-9.35%159.7M
-27.27%79.94M
28.14%18.76M
-8.43%212.29M
-12.08%176.17M
-24.60%109.92M
Net profit from continuing operation
33.20%212.73M
70.01%135.92M
187.19%53.87M
13.19%240.29M
-9.35%159.7M
-27.27%79.94M
28.14%18.76M
-8.43%212.29M
-12.08%176.17M
-24.60%109.92M
Less:Minority Profit
-6.40%-27.08M
12.63%-18.56M
13.94%-9.16M
---40.75M
---25.45M
---21.24M
---10.64M
----
----
----
Net profit of parent company owners
29.52%239.8M
52.66%154.47M
114.39%63.03M
32.39%281.04M
5.10%185.15M
-7.94%101.19M
100.84%29.4M
-8.43%212.29M
-12.08%176.17M
-24.60%109.92M
Earning per share
Basic earning per share
30.10%1.34
53.57%0.86
113.14%0.3472
32.15%1.5585
5.10%1.03
-8.20%0.56
100.62%0.1629
-8.42%1.1793
-11.71%0.98
-24.69%0.61
Diluted earning per share
30.10%1.34
0.00%0.86
81.97%0.3472
33.47%1.5585
8.42%1.03
45.76%0.86
102.55%0.1908
-4.15%1.1677
-15.18%0.95
-27.16%0.59
Other composite income
-112.48%-9.19M
-116.40%-12.52M
79.41%-26.69M
42.61%19.67M
6,584.17%73.63M
2,729.92%76.35M
-25,837.28%-129.63M
157.35%13.79M
91.48%-1.14M
168.40%2.7M
Other composite income of parent company owners
-110.47%-7.38M
-117.77%-13.25M
79.32%-21.14M
3.24%14.24M
6,307.64%70.49M
2,663.68%74.56M
-20,349.46%-102.21M
157.35%13.79M
91.48%-1.14M
168.40%2.7M
Other composite income of minority owners
-157.79%-1.81M
-59.14%730.16K
79.74%-5.56M
--5.43M
--3.14M
--1.79M
---27.43M
----
----
----
Total composite income
-12.77%203.53M
-21.05%123.39M
124.51%27.18M
14.99%259.96M
33.30%233.33M
38.79%156.29M
-884.19%-110.88M
8.80%226.08M
-6.43%175.03M
-20.60%112.61M
Total composite income of parent company owners
-9.08%232.42M
-19.64%141.22M
157.54%41.89M
30.61%295.28M
46.05%255.63M
56.06%175.75M
-614.94%-72.81M
8.80%226.08M
-6.43%175.03M
-20.60%112.61M
Total composite income of minority owners
-29.51%-28.89M
8.36%-17.83M
61.35%-14.72M
---35.32M
---22.31M
---19.45M
---38.07M
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Deloitte Huayong Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 21.80%3.05B28.85%1.99B35.51%951.5M42.87%3.58B39.96%2.5B39.00%1.54B66.69%702.16M5.84%2.51B2.31%1.79B-4.60%1.11B
Operating revenue 21.80%3.05B28.85%1.99B35.51%951.5M42.87%3.58B39.96%2.5B39.00%1.54B66.69%702.16M5.84%2.51B2.31%1.79B-4.60%1.11B
Other operating revenue ----270.72%13.91M-----1.94%13.91M----8.96%3.75M-----62.66%14.19M----11.54%3.44M
Total operating cost 22.03%2.81B26.36%1.83B28.65%879.05M46.34%3.31B43.91%2.31B44.60%1.44B63.13%683.27M7.19%2.26B4.44%1.6B-0.63%998.97M
Operating cost 19.95%2.1B24.11%1.35B29.99%660.17M44.76%2.5B41.85%1.75B44.14%1.09B67.65%507.88M8.27%1.73B6.16%1.23B-0.52%756.11M
Operating tax surcharges 38.68%22.13M40.79%13.31M51.47%6.94M50.90%22.41M45.57%15.96M30.74%9.45M52.77%4.58M3.17%14.85M4.09%10.96M2.93%7.23M
Operating expense 25.62%232.82M36.31%155.86M39.75%73.09M113.33%277.61M113.85%185.35M127.55%114.35M132.01%52.3M-12.58%130.13M-18.06%86.67M-28.10%50.25M
Administration expense 20.98%296.97M19.49%197.65M10.74%91.97M15.24%350.83M14.23%245.46M16.08%165.41M35.91%83.05M24.45%304.44M25.12%214.88M26.42%142.49M
Financial expense 87.03%66.06M103.02%38.5M31.80%16.08M629.63%52.31M1,124.70%35.32M480.90%18.96M15.93%12.2M-72.79%7.17M-113.32%-3.45M-78.63%3.26M
-Interest expense (Financial expense) 46.78%73.39M43.50%45.96M53.90%17.8M48.58%61.86M265.74%50M263.41%32.02M143.46%11.56M209.88%41.63M-55.40%13.67M-47.03%8.81M
-Interest Income (Financial expense) 44.53%-4.86M-4.29%-3.4M21.93%-1.4M39.40%-7.02M-1.89%-8.76M26.42%-3.26M26.33%-1.79M-65.57%-11.58M33.25%-8.6M41.09%-4.43M
Research and development 30.68%98.63M44.73%67.29M36.99%30.79M36.89%110.49M24.24%75.47M17.35%46.5M20.05%22.48M-2.97%80.72M2.53%60.75M-1.91%39.62M
Credit Impairment Loss 132.40%146.18K-52.08%1.16M-95.91%69.47K-29.64%-5.18M-128.20%-451.13K433.55%2.42M-38.93%1.7M-314.19%-3.99M260.80%1.6M45.66%-725.99K
Asset Impairment Loss -169.52%-2.23M9.68%-2.03M-242.54%-1.36M108.15%405.38K62.37%-828.29K21.30%-2.24M51.42%-397.78K-142.00%-4.98M-207.12%-2.2M-4,402.67%-2.85M
Adjustment items of total operating cost --------------------------780.11K------------
Other net revenue 2,488.44%12.2M189.41%7.57M-92.47%457.3K-43.99%11.58M-98.05%471.35K-85.19%2.62M-60.39%6.08M-35.48%20.67M4.17%24.17M28.27%17.67M
Fair value change income 133.46%4.29M137.52%2.62M242.62%2.74M-3,421.47%-57.67M-2,212.21%-12.82M-42,632.57%-6.98M-59.87%800.27K-56.51%-1.64M241.97%606.77K98.65%-16.33K
Invest income -194.20%-3.75M-239.60%-3.75M-589.44%-4.87M-90.51%2.22M-66.78%3.98M-78.26%2.69M-76.08%994.85K-7.13%23.39M-20.63%11.99M15.78%12.37M
Asset deal income 476.25%131.96K180.12%131.96K--131.96K-76.37%34.01K59.13%22.9K261.50%47.11K-----5.92%143.93K101.76%14.39K1,547.71%13.03K
Other revenue 28.93%13.62M41.34%9.44M25.72%3.75M827.75%71.77M-13.14%10.56M-24.80%6.68M-58.67%2.98M-28.06%7.74M10.02%12.16M55.81%8.88M
Operating profit 24.99%246.93M67.88%172.81M192.06%72.91M6.40%282.02M-5.99%197.56M-20.88%102.94M40.68%24.97M-8.54%265.06M-11.35%210.15M-25.01%130.1M
Add:Non operating Income 41.55%1.82M217.14%1.7M371.52%1.15M60.77%1.36M55.16%1.29M-57.05%536.65K-78.61%244.59K-58.20%848.83K-8.74%828.46K54.80%1.25M
Less:Non operating expense 222.03%6.8M769.66%6.33M1,557.87%4.74M-29.57%10.13M-75.43%2.11M-88.78%727.87K-73.64%286.1K31.45%14.39M3.33%8.59M162.33%6.49M
Total profit 22.98%241.95M63.69%168.19M178.15%69.32M8.64%273.26M-2.79%196.73M-17.71%102.75M39.99%24.92M-10.46%251.52M-11.87%202.39M-27.33%124.86M
Less:Income tax cost -21.08%29.22M41.51%32.27M150.64%15.45M-15.97%32.97M41.23%37.03M52.58%22.8M94.75%6.17M-20.04%39.23M-10.40%26.22M-42.62%14.95M
Net profit 33.20%212.73M70.01%135.92M187.19%53.87M13.19%240.29M-9.35%159.7M-27.27%79.94M28.14%18.76M-8.43%212.29M-12.08%176.17M-24.60%109.92M
Net profit from continuing operation 33.20%212.73M70.01%135.92M187.19%53.87M13.19%240.29M-9.35%159.7M-27.27%79.94M28.14%18.76M-8.43%212.29M-12.08%176.17M-24.60%109.92M
Less:Minority Profit -6.40%-27.08M12.63%-18.56M13.94%-9.16M---40.75M---25.45M---21.24M---10.64M------------
Net profit of parent company owners 29.52%239.8M52.66%154.47M114.39%63.03M32.39%281.04M5.10%185.15M-7.94%101.19M100.84%29.4M-8.43%212.29M-12.08%176.17M-24.60%109.92M
Earning per share
Basic earning per share 30.10%1.3453.57%0.86113.14%0.347232.15%1.55855.10%1.03-8.20%0.56100.62%0.1629-8.42%1.1793-11.71%0.98-24.69%0.61
Diluted earning per share 30.10%1.340.00%0.8681.97%0.347233.47%1.55858.42%1.0345.76%0.86102.55%0.1908-4.15%1.1677-15.18%0.95-27.16%0.59
Other composite income -112.48%-9.19M-116.40%-12.52M79.41%-26.69M42.61%19.67M6,584.17%73.63M2,729.92%76.35M-25,837.28%-129.63M157.35%13.79M91.48%-1.14M168.40%2.7M
Other composite income of parent company owners -110.47%-7.38M-117.77%-13.25M79.32%-21.14M3.24%14.24M6,307.64%70.49M2,663.68%74.56M-20,349.46%-102.21M157.35%13.79M91.48%-1.14M168.40%2.7M
Other composite income of minority owners -157.79%-1.81M-59.14%730.16K79.74%-5.56M--5.43M--3.14M--1.79M---27.43M------------
Total composite income -12.77%203.53M-21.05%123.39M124.51%27.18M14.99%259.96M33.30%233.33M38.79%156.29M-884.19%-110.88M8.80%226.08M-6.43%175.03M-20.60%112.61M
Total composite income of parent company owners -9.08%232.42M-19.64%141.22M157.54%41.89M30.61%295.28M46.05%255.63M56.06%175.75M-614.94%-72.81M8.80%226.08M-6.43%175.03M-20.60%112.61M
Total composite income of minority owners -29.51%-28.89M8.36%-17.83M61.35%-14.72M---35.32M---22.31M---19.45M---38.07M------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Deloitte Huayong Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data